FDA okays Eli Lilly’s new weight-loss pill, expanding options for millions
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
The inspection is now closed, and no regulatory action has been recommended
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
The Flonase Allergy Relief Nasal Spray, 50 mcg per spray market achieved annual sales of approximately $384.7 million
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
Subscribe To Our Newsletter & Stay Updated